LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM PHARMA
02 1INSMED
03 1IPSEN INC
04 1TARGACEPT
Reset all filters
01 2INJECTABLE;SUBCUTANEOUS
02 2TABLET;ORAL
Reset all filters
01 1DISCN
02 1RX
03 2Blank
Reset all filters
01 1INCRELEX
02 1INVERSINE
03 1IPLEX
04 1MECAMYLAMINE HYDROCHLORIDE
01 1No
02 1Yes
03 2Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
RLD : No
TE Code :
Brand Name : MECAMYLAMINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Approval Date : 2013-03-19
Application Number : 204054
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : Yes
TE Code :
Brand Name : INVERSINE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 10251
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD :
TE Code :
MECASERMIN RINFABATE RECOMBINANT
Brand Name : IPLEX
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 36MG/0.6ML
Approval Date :
Application Number : 21884
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : INCRELEX
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/4ML (10MG/ML)
Approval Date :
Application Number : 21839
RX/OTC/DISCN :
RLD :
TE Code :